Evidence map›Paper›PMID 41502706›Full record

ArticleACS omega2025

From NO to NTe:

Vinícius Glitz, Richard Fragnani Cardoso, Giovanni Finoto Caramori, Luis Henrique da Silveira Lacerda

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vinícius GlitzGroup of Molecular Electronic Structure and Materials, Departamento de Química, Universidade Federal de Santa Catarina, Campus Universitário Trindade, Florianópolis, SC 88040-900, Brasil.ORCID https://orcid.org/0000-0001-7245-2522
Richard Fragnani CardosoGroup of Molecular Electronic Structure and Materials, Departamento de Química, Universidade Federal de Santa Catarina, Campus Universitário Trindade, Florianópolis, SC 88040-900, Brasil.
Giovanni Finoto CaramoriGroup of Molecular Electronic Structure and Materials, Departamento de Química, Universidade Federal de Santa Catarina, Campus Universitário Trindade, Florianópolis, SC 88040-900, Brasil.ORCID https://orcid.org/0000-0002-6455-7831
Luis Henrique da Silveira LacerdaGroup of Molecular Electronic Structure and Materials, Departamento de Química, Universidade Federal de Santa Catarina, Campus Universitário Trindade, Florianópolis, SC 88040-900, Brasil.ORCID https://orcid.org/0000-0001-5926-7074

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ruthenium compounds bearing chalcogenonitrosyl ligands (NE, where E = O, S, Se, Te) represent a unique class of molecules with intriguing bonding patterns and potential relevance in redox-active systems. This manuscript presents a systematic investigation of a series of ruthenium-chalcogenonitrosyl compounds through combined Density Functional Theory (DFT) and generalized Kohn-Sham energy decomposition analysis (GKS-EDA) calculations. The compounds were evaluated both before and after one-electron reduction, focusing on their structural and electronic properties. Our results reveal clear trends in geometry, bond strength, and charge distribution, providing insight into the fundamental bonding interactions that govern the stability and redox behavior of these species. In particular, we examine the nature of the Ru-NE bond across the chalcogen series and evaluate the effects of one-electron reduction on these systems. The results demonstrate that one-electron reduction favors the labilization of the chalcogenonitrosyl ligands, as demonstrated by spin density plots and wave function analyses. The total interaction energy (Δ

Identifiers

PMID41502706
PMCPMC12771179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.